[Activity of paclitaxel, epirubicin and carboplatin in patients with advanced or recurrent endometrial cancer]

Nihon Rinsho. 2004 Oct:62 Suppl 10:360-4.

[Article in Japanese]

Authors

Ryuichi Nakashima¹, Takayuki Enomoto, Yuji Murata, Masami Fujita

Affiliation

¹ Department of Obstetrics and Gynecology, Faculty of Medicine, Osaka University.

PMID: 15535268

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carboplatin / administration & dosage
Carboplatin / adverse effects
Chemotherapy, Adjuvant
Endometrial Neoplasms / pathology
Endometrial Neoplasms / therapy*
Epirubicin / administration & dosage
Epirubicin / adverse effects
Female
Humans
Neoplasm Recurrence, Local / therapy
Neoplasm Staging
Paclitaxel / administration & dosage
Paclitaxel / adverse effects
Postoperative Care
Radiotherapy, Adjuvant
Randomized Controlled Trials as Topic
Treatment Outcome

Substances

Epirubicin
Carboplatin
Paclitaxel